Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of GW685698X (Fluticasone Furoate) in Persistent Bronchial Asthma
NCT01499446Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- Mar 2004
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
A Phase 2 trial of fluticasone in asthma, sponsored by GSK. Started Sep 2003; status: completed.
02
Drugs
fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01499446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01499446.